(Q34348505)

1 August 2017

Identification of submicroscopic genetic changes and precise breakpoint mapping in myelofibrosis using high resolution mate-pair sequencing (English)

1 reference

1 August 2017

1 reference

1 reference

7

Ayalew Tefferi

1 reference

1 August 2017

Terra Lasho

1

1 reference

1 August 2017

Sarah H Johnson

2

1 reference

1 August 2017

David I Smith

3

1 reference

1 August 2017

John D Crispino

4

1 reference

1 August 2017

Animesh Pardanani

5

1 reference

1 August 2017

George Vasmatzis

6

1 reference

1 August 2017

1 August 2013

1 reference

American Journal of Hematology

1 August 2017

1 reference

1 August 2017

88

1 reference

1 August 2017

9

1 reference

1 August 2017

741-746

1 reference

Perspectives on the development of a molecularly targeted agent

1 August 2017

1 reference

Mutations galore in myeloproliferative neoplasms: would the real Spartacus please stand up?

21 January 2018

1 reference

LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations

21 January 2018

1 reference

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms.

21 January 2018

1 reference

IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F

21 January 2018

1 reference

Deletions of the transcription factor Ikaros in myeloproliferative neoplasms.

21 January 2018

1 reference

DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms

21 January 2018

1 reference

Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms

21 January 2018

1 reference

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

21 January 2018

1 reference

Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management

21 January 2018

1 reference

Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management

21 January 2018

1 reference

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status

21 January 2018

1 reference

Karyotype complements the International Prognostic Scoring System for primary myelofibrosis.

21 January 2018

1 reference

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients

21 January 2018

1 reference

Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing

21 January 2018

1 reference

Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas.

21 January 2018

1 reference

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasia.

21 January 2018

1 reference

A 360-kb interchromosomal duplication of the human HYDIN locus

21 January 2018

1 reference

Frequent pathway mutations of splicing machinery in myelodysplasia

21 January 2018

1 reference

Identification of macrodomain proteins as novel O-acetyl-ADP-ribose deacetylases

21 January 2018

1 reference

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

21 January 2018

1 reference

Mutation in TET2 in myeloid cancers

21 January 2018

1 reference

Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity

21 January 2018

1 reference

Identification and characterization of EBP, a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN fusion protein

21 January 2018

1 reference

Functional contribution of EEN to leukemogenic transformation by MLL-EEN fusion protein

21 January 2018

1 reference

Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/AJH.23495

1 reference

1 August 2017

1 reference